Skip to content Skip to footer
Subscribe Now
Insights+: The US FDA New Drug Approvals in 2018
INSIGHTS+

Insights+: The US FDA New Drug Approvals in 2018

1. Janssen's Erleada (apalutamide) Receives FDA Approval for Non-Metastatic Castration-Resistant Prostate Cancer (NM-CRPC) Published: 14 Feb,2018 | Tags: Janssen, Erleada, apalutamide, Receives, FDA, Approval, Non-Metastatic Castration-Resistant Prostate Cancer, NM-CRPC 2. Helsinn's (fosnetupitant + palonosetron) Receives FDA Approval for Managing Chemotherapy-Induced Nausea and Vomiting (CINV) Published: 14 Feb,2018 | Tags: Helsins, fosnetupitant + palonosetron, Receives, FDA, Approval, Managing Chemotherapy-Induced Nausea and Vomiting,…
March 4, 2019

Read more

PharmaShots Year in Review: Biosimilars Approvals in 2018
INSIGHTS+

PharmaShots Year in Review: Biosimilars Approvals in 2018

THE US FDA APPROVALS  1.  Pfizer's Retacrit (epoetin alfa-epbx, biosimilar) Receives FDA Approval for Anemia Published: 15 May, 2018  | Tags: Pfizer, Retacrit, epoetinalfa-epbx, biosimilar, Receives, FDA, Approval, Anemia 2.   Pfizer's Nivestym (filgrastim-aafi, biosmilar) Receives FDA Approval for Neutropenia   Published: 20 Jul, 2018 | Tags: (filgrastim-aafi approval biosmilar), Neutropenia, Nivestym, Pfizer, Receives, the US FDA 3.  Sandoz's Hymiroz (adalimumab-adaz, biosimilar) Receives the US FDA…
January 8, 2019

Read more

PharmaShots' Most Read News of 2018
INSIGHTS+

PharmaShots’ Most Read News of 2018

PharmaShots' Most Read News of 2018 | Top 10 Pharma News of 2018  1. Celgene to Acquire Juno for its Cellular Immunotherapy & Hematology Portfolio Published: 22 Jan, 2018 | Tags: Celgene,  Acquire, Juno, Cellular, Immunotherapy, Hematology Portfolio 2.  Sanofi to Acquire Bioverativ for its Hemophilia Products Published: 22 Jan, 2018 | Tags: Sanofi, Acquire, Bioverativ, Treat,…
January 2, 2019

Read more